Φορτώνει......
Fluconazole in the treatment of Cushing's disease
Ketoconazole was a first-line agent for suppressing steroidogenesis in Cushing's disease. It now has limited availability. Fluconazole, another azole antifungal, is an alternative, although its in vivo efficacy is unclear. A 61-year-old female presented with weight gain, abdominal striae and wo...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Endocrinol Diabetes Metab Case Rep |
|---|---|
| Κύριοι συγγραφείς: | , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Bioscientifica Ltd
2016
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4744941/ https://ncbi.nlm.nih.gov/pubmed/26858837 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EDM-15-0115 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|